Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 2378 | 2196 | 36.1 | 66% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 667 | 12573 | ANTIDEPRESSANTS//AGOMELATINE//MOCLOBEMIDE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | NORFLUOXETINE | Author keyword | 46 | 60% | 2% | 49 |
| 2 | FLUVOXAMINE | Author keyword | 29 | 21% | 6% | 126 |
| 3 | CITALOPRAM | Author keyword | 23 | 14% | 7% | 148 |
| 4 | SERTRALINE | Author keyword | 22 | 16% | 6% | 126 |
| 5 | PAROXETINE | Author keyword | 16 | 12% | 6% | 126 |
| 6 | NEFAZODONE | Author keyword | 15 | 29% | 2% | 44 |
| 7 | DESMETHYLCITALOPRAM | Author keyword | 9 | 83% | 0% | 5 |
| 8 | FLUVOXAMINO ACID | Author keyword | 9 | 83% | 0% | 5 |
| 9 | FLUOXETINE HYDROCHLORIDE | Author keyword | 6 | 41% | 1% | 11 |
| 10 | FLUVOXAMINE MALEATE | Author keyword | 5 | 54% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NORFLUOXETINE | 46 | 60% | 2% | 49 | Search NORFLUOXETINE | Search NORFLUOXETINE |
| 2 | FLUVOXAMINE | 29 | 21% | 6% | 126 | Search FLUVOXAMINE | Search FLUVOXAMINE |
| 3 | CITALOPRAM | 23 | 14% | 7% | 148 | Search CITALOPRAM | Search CITALOPRAM |
| 4 | SERTRALINE | 22 | 16% | 6% | 126 | Search SERTRALINE | Search SERTRALINE |
| 5 | PAROXETINE | 16 | 12% | 6% | 126 | Search PAROXETINE | Search PAROXETINE |
| 6 | NEFAZODONE | 15 | 29% | 2% | 44 | Search NEFAZODONE | Search NEFAZODONE |
| 7 | DESMETHYLCITALOPRAM | 9 | 83% | 0% | 5 | Search DESMETHYLCITALOPRAM | Search DESMETHYLCITALOPRAM |
| 8 | FLUVOXAMINO ACID | 9 | 83% | 0% | 5 | Search FLUVOXAMINO+ACID | Search FLUVOXAMINO+ACID |
| 9 | FLUOXETINE HYDROCHLORIDE | 6 | 41% | 1% | 11 | Search FLUOXETINE+HYDROCHLORIDE | Search FLUOXETINE+HYDROCHLORIDE |
| 10 | FLUVOXAMINE MALEATE | 5 | 54% | 0% | 7 | Search FLUVOXAMINE+MALEATE | Search FLUVOXAMINE+MALEATE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NORFLUOXETINE | 38 | 42% | 3% | 71 |
| 2 | DEMETHYLATED METABOLITES | 28 | 58% | 1% | 32 |
| 3 | SPARTEINE OXIDATION POLYMORPHISM | 27 | 55% | 2% | 34 |
| 4 | CLOVOXAMINE | 26 | 100% | 1% | 11 |
| 5 | NORFLUOXETINE ENANTIOMERS | 26 | 67% | 1% | 24 |
| 6 | RACEMIC CITALOPRAM | 25 | 75% | 1% | 18 |
| 7 | FLUVOXAMINE MALEATE | 23 | 86% | 1% | 12 |
| 8 | COMPARING PAROXETINE | 22 | 81% | 1% | 13 |
| 9 | ACTIVE METABOLITE NORFLUOXETINE | 21 | 90% | 0% | 9 |
| 10 | ACTIVE METABOLITES | 18 | 28% | 3% | 55 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability | 2000 | 408 | 121 | 90% |
| Pharmacokinetics of selective serotonin reuptake inhibitors | 2000 | 343 | 149 | 72% |
| Clinically relevant pharmacology of selective serotonin reuptake inhibitors - An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism | 1997 | 230 | 104 | 77% |
| Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions | 2012 | 24 | 230 | 60% |
| Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update | 2008 | 122 | 150 | 47% |
| Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review | 2003 | 254 | 155 | 45% |
| Newer antidepressants and the cytochrome P450 system | 1996 | 371 | 73 | 51% |
| Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: An update | 2002 | 147 | 167 | 62% |
| TREATMENT DISCONTINUATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS COMPARED WITH TRICYCLIC ANTIDEPRESSANTS - A METAANALYSIS | 1995 | 233 | 92 | 86% |
| Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram | 2001 | 86 | 54 | 65% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | UNITE BIOCHIM PSYCHOPHARMACOL CLIN | 4 | 24% | 0.6% | 13 |
| 2 | HOP DE CERY | 1 | 50% | 0.1% | 2 |
| 3 | NEBRASKA MED 985580 | 1 | 40% | 0.1% | 2 |
| 4 | WOMEN STUDENT MED STUDIES SECT | 1 | 25% | 0.1% | 3 |
| 5 | UNITE BIOCHIM PSYCHOPHARMACOL | 1 | 33% | 0.1% | 2 |
| 6 | PSYCHIAT ADULTE | 1 | 11% | 0.3% | 6 |
| 7 | ANALYT PHARMACEUT CHEMCIRM | 1 | 50% | 0.0% | 1 |
| 8 | CHAIR PHARMACOL MED | 1 | 50% | 0.0% | 1 |
| 9 | CHS JURY | 1 | 50% | 0.0% | 1 |
| 10 | CLIN PSYCHIAT 2 | 1 | 50% | 0.0% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000219240 | VENLAFAXINE//MILNACIPRAN//ESCITALOPRAM |
| 2 | 0.0000167227 | MIRTAZAPINE//ORG 3770//C 11MIRTAZAPINE |
| 3 | 0.0000140669 | NORTRIPTYLINE//DESMETHYLCLOMIPRAMINE//DOXEPIN |
| 4 | 0.0000138772 | META NISOLDIPINE//VOLTAGE ACTIVATED//M NISOLDIPINE |
| 5 | 0.0000137815 | TRAZODONE//DESMETHYLMIANSERIN//ETOPERIDONE |
| 6 | 0.0000131406 | SEROTONIN SYNDROME//SEROTONIN TOXICITY//COMPLICATIONS SEROTONIN SYNDROME |
| 7 | 0.0000109973 | LITHIUM AUGMENTATION//RESISTANT DEPRESSION//DEP S CLIN PROGRAM |
| 8 | 0.0000103457 | REBOXETINE//SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITOR//SELECTIVE NRI |
| 9 | 0.0000101657 | ATOMOXETINE HYDROCHLORIDE//4 HYDROXYATOMOXETINE//ANTI DEPRESSANT DRUG |
| 10 | 0.0000098818 | BUPROPION//HYDROXYBUPROPION//WELLBUTRIN |